Knight Cancer Institute

Research output

Research output per year 1972 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 5677 Article
• 743 Review article
• 380 Comment/debate
• 301 Letter
• 546 More
  • 239 Chapter
  • 141 Editorial
  • 70 Conference contribution
  • 60 Short survey
  • 23 Conference article
  • 6 Book
  • 6 Foreword/postscript
  • 1 Paper

Research output per year

Research output per year

Search results

• 2023

  Autoimmunity May Explain Diabetes in a Subset of Patients With Recurrent Acute and Chronic Pancreatitis: A Pilot Study

  North American Pancreatitis Studies Consortium, Jan 2023, In: Clinical Gastroenterology and Hepatology. 21, 1, p. 226-228.e1

  Research output: Contribution to journal › Short survey › peer-review
  5 Scopus citations

• Pancreatitis-Associated PRSS1-PRSS2 Haplotype Alters T-Cell Receptor Beta (TRB) Repertoire More Strongly Than PRSS1 Expression

  Prospective Autos Study, GREAT1 Study & North American Pancreatitis Study Group, Feb 2023, In: Gastroenterology. 164, 2, p. 289-292.e4

  Research output: Contribution to journal › Short survey › peer-review

  Open Access
  3 Scopus citations

• Role of white matter hyperintensity in effects of apolipoprotein E on cognitive injury

  Raber, J. & Silbert, L. C., 2023, In: Frontiers in Human Neuroscience. 17, 1176690.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • Apolipoproteins E 100%
  • White Matter 85%
  • Protein Isoforms 54%
  • Wounds and Injuries 45%
  • Human ApoE protein 43%

• The impact of inflammation and acute phase activation in cancer cachexia

  Robinson, T. P., Hamidi, T., Counts, B., Guttridge, D. C., Ostrowski, M. C., Zimmers, T. A. & Koniaris, L. G., 2023, In: Frontiers in immunology. 14, 1207746.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • Cachexia 100%
  • Acute-Phase Reaction 58%
  • Inflammation 48%
  • Acute-Phase Proteins 27%
  • Neoplasms 26%
• 2021

  Getting Primary Care — A Life-Saving Intervention — Off Life Support

  DeVoe, J. E., Apr 2021, In: Mayo Clinic Proceedings. 96, 4, p. 870-874 5 p.

  Research output: Contribution to journal › Short survey › peer-review

• Landscape analysis of phase 2 and 3 clinical trials for targeted radionuclide therapy

  Mittra, E. & Bodei, L., Aug 1 2021, In: Journal of Nuclear Medicine. 62, 8, p. 1031-1032 2 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access
  4 Scopus citations

• Overstretched and overlooked: solving challenges faced by early-career investigators after the pandemic

  Humphries, B. A., Hwang, P. Y., Kendrick, A. A., Kulkarni, R. P., Pozzar, R. A. & San Martin, R., Oct 2021, In: Trends in Cancer. 7, 10, p. 879-882 4 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • Pandemics 100%
  • Research Personnel 65%
  • Coronavirus 59%
  5 Scopus citations

• Response to Comment on "Tumor-initiating cells establish an IL-33-TGF-p niche signaling loop to promote cancer progression"

  Taniguchi, S., Elhance, A., van Duzer, A., Kumar, S., Leitenberger, J. & Oshimori, N., Apr 9 2021, In: Science. 372, 6538

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • Interleukin-33 100%
  • Neoplastic Stem Cells 77%
  • Macrophages 51%
  • IgE Receptors 32%
  • Neoplasms 23%
  1 Scopus citations

• The Significance of Polyploid Hepatocytes During Aging Process

  Matsumoto, T., Wakefield, L. & Grompe, M., Jan 2021, In: CMGH. 11, 5, p. 1347-1349 3 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access
  8 Scopus citations
• 2020

  A Timeline of Immune Checkpoint Inhibitor Approvals in Small Cell Lung Cancer

  Gill, J., Cetnar, J. P. & Prasad, V., Sep 2020, In: Trends in Cancer. 6, 9, p. 736-738 3 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • TimeLine 100%
  • Small Cell Lung Carcinoma 84%
  • Pharmaceutical Preparations 31%
  • Clinical Trials 24%
  5 Scopus citations

• Ponatinib coronary microangiopathy: Novel bedside diagnostic approach and management with N-acetylcysteine

  Wu, M. D., Hodovan, J., Kumar, K., Moulton, B., Olson, S., Gilbert, A., Wood, M. D. & Lindner, J. R., Sep 8 2020, In: Blood Advances. 4, 17, p. 4083-4085 3 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access
  7 Scopus citations
• 2019

  Interpreting the Effectiveness of Cancer Screening From National Population Statistics: Is It Sound Practice?

  Chapa, J., Haslam, A. & Prasad, V., Jun 2019, In: Mayo Clinic Proceedings. 94, 6, p. 951-956 6 p.

  Research output: Contribution to journal › Short survey › peer-review
  1 Scopus citations

• Management of Chronic Dyspnea #376

  Weinberg, R. & Ketterer, B., Jul 2019, In: Journal of palliative medicine. 22, 7, p. 858-860 3 p.

  Research output: Contribution to journal › Short survey › peer-review
  2 Scopus citations

• Real-world Evidence - What Does It Really Mean?

  Nabhan, C., Klink, A. & Prasad, V., Jun 2019, In: JAMA Oncology. 5, 6, p. 781-783 3 p.

  Research output: Contribution to journal › Short survey › peer-review
  37 Scopus citations
• 2018

  Advanced imaging of multiple myeloma bone disease

  Hansford, B. G. & Silbermann, R., Aug 7 2018, In: Frontiers in Endocrinology. 9, AUG, 436.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • Bone Diseases 100%
  • Multiple Myeloma 88%
  • Technology 23%
  • Spontaneous Fractures 22%
  • Bone and Bones 21%
  19 Scopus citations

• Cancer drugs approved based on biomarkers and not tumor type - FDA approval of pembrolizumab for mismatch repair-deficient solid cancers

  Prasad, V., Kaestner, V. & Mailankody, S., Feb 2018, In: JAMA Oncology. 4, 2, p. 157-158 2 p.

  Research output: Contribution to journal › Short survey › peer-review
  100 Scopus citations

• Making room

  Lycette, J., Jun 26 2018, In: JAMA - Journal of the American Medical Association. 319, 24, p. 2479-2480 2 p.

  Research output: Contribution to journal › Short survey › peer-review
• 2017

  A life without hunger: The Ups (and downs) to modulating melanocortin-3 receptor signaling

  Butler, A. A., Girardet, C., Mavrikaki, M., Trevaskis, J. L., Macarthur, H., Marks, D. L. & Farr, S. A., Mar 16 2017, In: Frontiers in Neuroscience. 11, MAR, 128.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • Receptor, Melanocortin, Type 3 100%
  • Hunger 73%
  • Nutrients 51%
  • Mouse Mc3r protein 48%
  • Neurons 27%
  26 Scopus citations

• Axon Degeneration: Too Much NMN Is Actually Bad?

  Cohen, M. S., Apr 24 2017, In: Current Biology. 27, 8, p. R310-R312

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • Mononucleotide 100%
  • Nicotinamide 81%
  • axons 77%
  • Adenine 69%
  • Axons 66%
  3 Scopus citations

• Endogenous retroviruses: With us and against us

  Meyer, T. J., Rosenkrantz, J. L., Carbone, L. & Chavez, S. L., 2017, In: Frontiers in Chemistry. 5, APR, 23.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • Disorder 100%
  • Mutation 98%
  • Modification 64%
  • Protein 48%
  45 Scopus citations

• Health policy: Me-too drugs with limited benefits-the tale of regorafenib for HCC

  Gyawali, B. & Prasad, V., Nov 1 2017, In: Nature Reviews Clinical Oncology. 14, 11, p. 653-654 2 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access
  19 Scopus citations

• Medicine: The final frontier in cancer diagnosis

  Leachman, S. A. & Merlino, G., Feb 2 2017, In: Nature. 542, 7639, p. 36-38 3 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access
  41 Scopus citations

• neonatal venous thromboembolism

  Haley, K. M., Jun 6 2017, In: Frontiers in Pediatrics. 5, 136.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • Venous Thromboembolism 100%
  • Newborn Infant 33%
  • Hemostatics 26%
  • Thrombophilia 14%
  • Critical Illness 11%
  40 Scopus citations

• Overall survival in cancer drug trials as a new surrogate end point for overall survival in the real world

  Mailankody, S. & Prasad, V., Jul 2017, In: JAMA Oncology. 3, 7, p. 889-890 2 p.

  Research output: Contribution to journal › Short survey › peer-review
  30 Scopus citations

• PDGFRA Antibody for Soft Tissue Sarcoma

  Klug, L. R. & Heinrich, M. C., Feb 9 2017, In: Cell. 168, 4, p. 555 1 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • olaratumab 100%
  • Doxorubicin 53%
  • Sarcoma 48%
  • Block Like Crystal 34%
  • Antibodies 28%
  6 Scopus citations

• Pharmaceutical marketing for rare diseases: Regulating drug company promotion in an era of unprecedented advertisement

  Mailankody, S. & Prasad, V., Jun 27 2017, In: JAMA - Journal of the American Medical Association. 317, 24, p. 2479-2480 2 p.

  Research output: Contribution to journal › Short survey › peer-review
  10 Scopus citations

• Should chemotherapy be used in nonmetastatic prostate cancer?

  Graff, J. N., Alumkal, J. J. & Beer, T. M., Jan 1 2017, In: JAMA Oncology. 3, 1, p. 11-12 2 p.

  Research output: Contribution to journal › Short survey › peer-review
  3 Scopus citations

• Taking care of our friends and neighbors: DeVita’s the death of cancer and the challenge of letting go

  Beer, T. M. & Prasad, V., Jan 1 2017, In: JAMA Oncology. 3, 1, p. 16-17 2 p.

  Research output: Contribution to journal › Short survey › peer-review
  3 Scopus citations

• The puzzle table

  Lycette, J., Dec 1 2017, In: Journal of Clinical Oncology. 35, 34, p. 3888-3889 2 p.

  Research output: Contribution to journal › Short survey › peer-review
• 2016

  Application of medicare's new technology add-on payment program for blinatumomab

  Dhruva, S. S. & Prasad, V., Feb 2016, In: JAMA Oncology. 2, 2, p. 165-166 2 p.

  Research output: Contribution to journal › Short survey › peer-review
  3 Scopus citations

• Blood-based screening for colon cancer: A disruptive innovation or simply a disruption?

  Parikh, R. B. & Prasad, V., Jun 21 2016, In: JAMA - Journal of the American Medical Association. 315, 23, p. 2519-2520 2 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access
  29 Scopus citations

• Duration of adjuvant therapy for patients with gastrointestinal stromal tumors: Where is goldilocks when we need her?

  Blanke, C. D. & DeMatteo, R. P., Jun 2016, In: JAMA Oncology. 2, 6, p. 721-722 2 p.

  Research output: Contribution to journal › Short survey › peer-review
  6 Scopus citations

• How should research be funded? Difficulties with the argument for proportionality to causes of death or years of life lost

  Prasad, V., Mar 1 2016, In: JNCCN Journal of the National Comprehensive Cancer Network. 14, 3, p. 365-366 2 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access
  1 Scopus citations

• Implications of proposed medicare reforms to counteract high cancer drug prices

  Mailankody, S. & Prasad, V., Jul 19 2016, In: JAMA - Journal of the American Medical Association. 316, 3, p. 271-272 2 p.

  Research output: Contribution to journal › Short survey › peer-review
  26 Scopus citations

• Malignant pleural effusions

  Semaan, R., Feller-Kopman, D., Slatore, C., Sockrider, M. & Powell, C., Sep 15 2016, In: American journal of respiratory and critical care medicine. 194, 6, p. P11-P12

  Research output: Contribution to journal › Short survey › peer-review

  Open Access
  5 Scopus citations

• Neglected - Cancer care and mental health in rural America

  Lycette, J., Dec 8 2016, In: New England Journal of Medicine. 375, 23, p. 2220-2221 2 p.

  Research output: Contribution to journal › Short survey › peer-review
  3 Scopus citations

• Rethinking radical cystectomy as the best choice for most patients with muscle-invasive bladder cancer

  Mitin, T., Jul 2016, In: JAMA Oncology. 2, 7, p. 856-858 3 p.

  Research output: Contribution to journal › Short survey › peer-review
  2 Scopus citations

• The UK Cancer Drugs Fund Experiment and the US Cancer Drug Cost Problem: Bearing the Cost of Cancer Drugs Until It Is Unbearable

  Prasad, V. & Mailankody, S., Jun 1 2016, In: Mayo Clinic Proceedings. 91, 6, p. 707-712 6 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access
  20 Scopus citations
• 2015

  Adeno-associated virus finds its disease

  Russell, D. W. & Grompe, M., Sep 29 2015, In: Nature genetics. 47, 10, p. 1104-1105 2 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • Adeno-associated virus-2 100%
  • Dependovirus 81%
  • Proto-Oncogenes 77%
  • Genetic Therapy 61%
  • Serogroup 60%
  32 Scopus citations

• In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

  Tefferi, A., Kantarjian, H., Rajkumar, S. V., Baker, L. H., Abkowitz, J. L., Adamson, J. W., Advani, R. H., Allison, J., Antman, K. H., Bast, R. C., Bennett, J. M., Benz, E. J., Berliner, N., Bertino, J., Bhatia, R., Bhatia, S., Bhojwani, D., Blanke, C. D., Bloomfield, C. D., Bosserman, L., & 95 othersBroxmeyer, H. E., Byrd, J. C., Cabanillas, F., Canellos, G. P., Chabner, B. A., Chanan-Khan, A., Cheson, B., Clarkson, B., Cohn, S. L., Colon-Otero, G., Cortes, J., Coutre, S., Cristofanilli, M., Curran, W. J., Daley, G. Q., Deangelo, D. J., Deeg, H. J., Einhorn, L. H., Erba, H. P., Esteva, F. J., Estey, E., Fidler, I. J., Foran, J., Forman, S., Freireich, E., Fuchs, C., George, J. N., Gertz, M. A., Giralt, S., Golomb, H., Greenberg, P., Gutterman, J., Handin, R. I., Hellman, S., Hoff, P. M., Hoffman, R., Hong, W. K., Horowitz, M., Hortobagyi, G. N., Hudis, C., Issa, J. P., Johnson, B. E., Kantoff, P. W., Kaushansky, K., Khayat, D., Khuri, F. R., Kipps, T. J., Kripke, M., Kyle, R. A., Larson, R. A., Lawrence, T. S., Levine, R., Link, M. P., Lippman, S. M., Lonial, S., Lyman, G. H., Markman, M., Mendelsohn, J., Meropol, N. J., Messinger, Y., Mulvey, T. M., O'Brien, S., Perez-Soler, R., Pollock, R., Prchal, J., Press, O., Radich, J., Rai, K., Rosenberg, S. A., Rowe, J. M., Rugo, H., Runowicz, C. D., Sandmaier, B. M., Saven, A., Schafer, A. I., Schiffer, C., Sekeres, M. A., Silver, R. T., Siu, L. L., Steensma, D. P., Stewart, F. M., Stock, W., Stone, R., Storb, R., Strong, L. C., Tallman, M. S., Thompson, M., Ueno, N. T., Van Etten, R. A., Vose, J. M., Wiernik, P. H., Winer, E. P., Younes, A., Zelenetz, A. D. & Lemaistre, C. A., Aug 1 2015, In: Mayo Clinic Proceedings. 90, 8, p. 996-1000 5 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access
  127 Scopus citations

• Losing "losing the battle with cancer"

  Ellis, L. M., Blanke, C. D. & Roach, N., Apr 1 2015, In: JAMA Oncology. 1, 1, p. 13-14 2 p.

  Research output: Contribution to journal › Short survey › peer-review
  18 Scopus citations
• 2014

  Functional genomics for personalized cancer therapy

  Tyner, J. W., Jul 2 2014, In: Science translational medicine. 6, 243, 243fs26.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • Genomics 100%
  • Neoplasms 31%
  • Therapeutics 16%
  13 Scopus citations

• Liver stem cells, where art thou?

  Grompe, M., 2014, In: Cell Stem Cell. 15, 3, p. 257-258 2 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access
  68 Scopus citations
• 2013

  A therapy for liver failure found in the JNK yard

  Willenbring, H. & Grompe, M., Apr 11 2013, In: Cell. 153, 2, p. 283-284 2 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • Liver Failure 100%
  • Hepatocytes 77%
  • Liver Regeneration 37%
  • Liver 31%
  • Therapeutics 15%
  5 Scopus citations
• 2012

  Do circulating tumor cells play a role in coagulation and thrombosis?

  Tormoen, G. W., Haley, K. M., Levine, R. L. & McCarty, O. J. T., 2012, In: Frontiers in Oncology. 2 SEP, Article 115.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • Circulating Neoplastic Cells 100%
  • Thrombosis 62%
  • Neoplasms 26%
  • Anticoagulants 22%
  • Thrombophilia 14%
  24 Scopus citations

• Genomics: The breast cancer landscape

  Gray, J. & Druker, B., Jun 21 2012, In: Nature. 486, 7403, p. 328-329 2 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access
  35 Scopus citations
• 2011

  Personalized cancer diagnostics

  Corless, C. L., Dec 2 2011, In: Science. 334, 6060, p. 1217-1218 2 p.

  Research output: Contribution to journal › Short survey › peer-review

  • Costs and Cost Analysis 100%
  • Neoplasms 51%
  23 Scopus citations

• Phosphoproteomics microarray screen reveals novel interaction between MPL and tensin2: Implications for biology, disease and therapeutics

  Tyner, J. W., Aug 15 2011, In: Cell Cycle. 10, 16, p. 2621 1 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access
• 2010

  Cancer: Oncogenes in context

  Heinrich, M. C. & Corless, C. L., Oct 14 2010, In: Nature. 467, 7317, p. 796-797 2 p.

  Research output: Contribution to journal › Short survey › peer-review
  5 Scopus citations

• Prostate cancer screening: What we have learned from the PLCO and ERSPC trials

  La Rochelle, J. & Amling, C. L., May 2010, In: Current urology reports. 11, 3, p. 198-201 4 p.

  Research output: Contribution to journal › Short survey › peer-review

  • Early Detection of Cancer 100%
  • Ovarian Neoplasms 96%
  • Colorectal Neoplasms 83%
  • Prostatic Neoplasms 83%
  • Lung Neoplasms 83%
  12 Scopus citations